- •Contents
- •General Introduction
- •Objectives
- •Anatomy
- •Eyelids
- •Conjunctiva
- •Lacrimal Functional Unit
- •The Tear Film
- •Cornea
- •Sclera
- •2 Examination Techniques for the External Eye and Cornea
- •Evaluation of Vision in the Patient With an Abnormal Cornea
- •External Examination
- •Slit-Lamp Biomicroscopy
- •Direct Illumination Methods
- •Indirect Illumination Methods
- •Clinical Use
- •Stains
- •Fluorescein
- •Rose Bengal and Lissamine Green
- •Evaluation of the Tear Film and Tests of Tear Production
- •Tear Composition Assays
- •Imaging Technologies
- •Impression Cytology
- •Corneal Pachymetry
- •Measurement of Corneal Biomechanics
- •Measurement of Corneal Curvature
- •Zones of the Cornea
- •Shape, Curvature, and Power
- •Keratometry
- •Computerized Corneal Topography
- •Corneal Tomography
- •Indications
- •Ultrasound Biomicroscopy
- •Anterior Segment Optical Coherence Tomography
- •Confocal Microscopy
- •External and Slit-Lamp Photography
- •Specular Microscopy
- •Anterior Segment Fluorescein Angiography
- •Esthesiometry
- •Retinoscopy
- •3 Clinical Approach to Ocular Surface Disorders
- •Common Clinical Findings
- •Conjunctival Signs
- •Corneal Signs
- •Clinical Approach to Dry Eye
- •Mechanisms of Dry Eye
- •Aqueous Tear Deficiency
- •Evaporative Dry Eye
- •Treatment of Dry Eye
- •Rosacea
- •Seborrheic Blepharitis
- •Staphylococcal Blepharitis
- •Hordeola and Chalazia
- •Exposure Keratopathy
- •Floppy Eyelid Syndrome
- •Superior Limbic Keratoconjunctivitis
- •Recurrent Corneal Erosion
- •Neurotrophic Keratopathy and Persistent Corneal Epithelial Defects
- •Trichiasis and Distichiasis
- •Factitious Ocular Surface Disorders
- •Dellen
- •Limbal Stem Cell Deficiency
- •Sjögren Syndrome
- •Ichthyosis
- •Ectodermal Dysplasia
- •Xeroderma Pigmentosum
- •Vitamin A Deficiency
- •4 Infectious Diseases of the External Eye: Basic Concepts and Viral Infections
- •Defense Mechanisms of the External Eye
- •Normal Ocular Flora
- •Pathogenesis of Ocular Infections
- •Virulence
- •Inoculum
- •Host Defense
- •Ocular Microbiology
- •Diagnostic Laboratory Techniques
- •Specimen Collection
- •Staining Methods
- •Virology and Viral Infections
- •DNA Viruses: Herpesviruses
- •Herpes Simplex Eye Diseases
- •Varicella-Zoster Virus Dermatoblepharitis, Conjunctivitis, and Keratitis
- •Epstein-Barr Virus Dacryoadenitis, Conjunctivitis, and Keratitis
- •Cytomegalovirus Keratitis and Anterior Uveitis
- •DNA Viruses: Adenoviruses
- •DNA Viruses: Poxviruses
- •Molluscum Contagiosum
- •Vaccinia
- •DNA Viruses: Papovaviruses
- •RNA Viruses
- •Bacteriology
- •Gram-positive Cocci
- •Gram-negative Cocci
- •Gram-positive Rods
- •Gram-negative Rods
- •Gram-positive Filaments
- •Chlamydia Species
- •Spirochetes
- •Mycology
- •Yeasts
- •Septate Filamentous Fungi
- •Nonseptate Filamentous Fungi
- •Parasitology
- •Protozoa
- •Helminths
- •Arthropods
- •Prions
- •Staphylococcal Blepharitis
- •Fungal and Parasitic Infections of the Eyelid Margin
- •Bacterial Conjunctivitis in Children and Adults
- •Parinaud Oculoglandular Syndrome
- •Microbial and Parasitic Infections of the Cornea and Sclera
- •Contact Lens–Related Infectious Keratitis
- •Bacterial Keratitis
- •Atypical Mycobacteria
- •Fungal Keratitis
- •Acanthamoeba Keratitis
- •Corneal Stromal Inflammation Associated With Systemic Infections
- •Microsporidiosis
- •Loiasis
- •Microbial Scleritis
- •6 Ocular Immunology
- •Overview of the Ocular Surface Immune Response
- •Tear Film
- •Immunoregulation of the Ocular Surface
- •Angiogenesis and Lymphangiogenesis in the Cornea
- •Tissue-Specific Patterns of Immune-Mediated Ocular Disease
- •Conjunctiva
- •Cornea
- •Sclera
- •Diagnostic Approach to Immune-Mediated Ocular Disorders
- •Immune-Mediated Diseases of the Eyelid
- •Contact Dermatoblepharitis
- •Atopic Dermatitis
- •Immune-Mediated Disorders of the Conjunctiva
- •Hay Fever Conjunctivitis and Perennial Allergic Conjunctivitis
- •Vernal Keratoconjunctivitis
- •Atopic Keratoconjunctivitis
- •Ligneous Conjunctivitis
- •Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
- •Mucous Membrane Pemphigoid
- •Ocular Graft-vs-Host Disease
- •Other Immune-Mediated Diseases of the Skin and Mucous Membranes
- •Immune-Mediated Diseases of the Cornea
- •Thygeson Superficial Punctate Keratitis
- •Interstitial Keratitis Associated With Infectious Diseases
- •Reactive Arthritis
- •Cogan Syndrome
- •Marginal Corneal Infiltrates Associated With Blepharoconjunctivitis
- •Peripheral Ulcerative Keratitis Associated With Systemic Immune-Mediated Diseases
- •Mooren Ulcer
- •Corneal Transplant Rejection
- •Immune-Mediated Diseases of the Episclera and Sclera
- •Episcleritis
- •Scleritis
- •8 Clinical Approach to Neoplastic Disorders of the Conjunctiva and Cornea
- •Approach to the Patient With a Neoplastic Conjunctival Lesion
- •Management of Patients With Conjunctival Tumors
- •Surgical Treatment
- •Topical Chemotherapy
- •Tumors of Epithelial Origin
- •Benign Epithelial Tumors
- •Preinvasive Epithelial Lesions
- •Malignant Epithelial Lesions
- •Management of Atypical Epithelial Tumors
- •Other Malignant Epithelial Lesions
- •Glandular Tumors of the Conjunctiva
- •Oncocytoma
- •Sebaceous Gland Carcinoma
- •Tumors of Neuroectodermal Origin
- •Benign Pigmented Lesions
- •Preinvasive Pigmented Lesions
- •Malignant Pigmented Lesions
- •Neurogenic and Smooth-Muscle Tumors
- •Vascular and Mesenchymal Tumors
- •Benign Tumors
- •Malignant Tumors
- •Lymphatic and Lymphocytic Tumors
- •Lymphangiectasia and Lymphangioma
- •Lymphoid Hyperplasia
- •Lymphoma
- •Metastatic Tumors
- •9 Basic and Clinical Concepts of Congenital Anomalies of the Cornea, Sclera, and Globe
- •Developmental Anomalies of the Globe and Sclera
- •Cryptophthalmos
- •Microphthalmos
- •Nanophthalmos
- •Blue Sclera
- •Developmental Anomalies of the Anterior Segment
- •Anomalies of Size and Shape of the Cornea
- •Abnormalities of Corneal Structure and/or Clarity
- •Secondary Abnormalities Affecting the Fetal Cornea
- •Intrauterine Keratitis: Bacterial and Syphilitic
- •Congenital Corneal Keloid
- •Congenital Corneal Anesthesia
- •Congenital Glaucoma
- •Birth Trauma
- •Arcus Juvenilis
- •10 Corneal Dystrophies and Ectasias
- •Corneal Dystrophies
- •Epithelial and Subepithelial Dystrophies
- •Bowman Layer Corneal Dystrophies
- •Stromal Corneal Dystrophies: TGFBI Dystrophies
- •Stromal Dystrophies: Non-TGFBI Dystrophies
- •Endothelial Dystrophies
- •Ectatic Disorders
- •Keratoconus
- •Pellucid Marginal Degeneration
- •Keratoglobus
- •11 Systemic Disorders With Corneal Changes
- •Disorders of Carbohydrate Metabolism
- •Mucopolysaccharidoses
- •Diabetes Mellitus
- •Disorders of Lipid Metabolism and Storage
- •Hyperlipoproteinemias
- •Hypolipoproteinemias
- •Sphingolipidoses
- •Mucolipidoses
- •Disorders of Amino Acid Metabolism
- •Cystinosis
- •Tyrosinemia
- •Alkaptonuria
- •Disorders of Protein Metabolism
- •Amyloidosis
- •Disorders of Immunoglobulin Synthesis
- •Noninflammatory Disorders of Connective Tissue
- •Ehlers-Danlos Syndrome
- •Marfan Syndrome
- •Disorders of Nucleotide Metabolism
- •Gout
- •Porphyria
- •Disorders of Mineral Metabolism
- •Wilson Disease
- •Hypercalcemia
- •Hemochromatosis
- •Corneal and External Disease Signs of Systemic Neoplasia
- •Enlarged Corneal Nerves
- •Appendix
- •12 Clinical Approach to Depositions and Degenerations of the Conjunctiva, Cornea, and Sclera
- •Degenerative Changes of the Conjunctiva
- •Age-Related (Involutional) Changes
- •Pinguecula
- •Pterygium
- •Conjunctival Concretions
- •Conjunctival Inclusion Cysts
- •Conjunctivochalasis
- •Conjunctival Vascular Tortuosity and Hyperemia
- •Degenerative Changes in the Cornea
- •Age-Related (Involutional) Changes
- •Epithelial and Subepithelial Degenerations
- •Stromal Degenerations
- •Endothelial Degenerations
- •Scleral Degenerations
- •Drug-Induced Deposition and Pigmentation
- •Corneal Epithelial Deposits
- •Stromal and Descemet Membrane Pigmentation
- •Endothelial Manifestations
- •13 Clinical Aspects of Toxic and Traumatic Injuries of the Anterior Segment
- •Injuries Caused by Temperature and Radiation
- •Thermal Burns
- •Ultraviolet Radiation
- •Ionizing Radiation
- •Chemical Injuries
- •Alkali Burns
- •Acid Burns
- •Management of Chemical Injuries
- •Toxic Keratoconjunctivitis From Medications
- •Pathogenesis
- •Clinical Presentation
- •Management
- •Animal and Plant Substances
- •Insect Injuries
- •Vegetation Injuries
- •Concussive Trauma
- •Subconjunctival Hemorrhage
- •Corneal Changes
- •Traumatic Mydriasis and Miosis
- •Traumatic Iritis
- •Iridodialysis and Cyclodialysis
- •Traumatic Hyphema
- •Nonperforating Mechanical Trauma
- •Conjunctival Laceration
- •Conjunctival Foreign Body
- •Corneal Foreign Body
- •Corneal Abrasion
- •Perforating Trauma
- •Evaluation
- •Management
- •Surgical Trauma
- •Corneal Epithelial Changes From Intraocular Surgery
- •Descemet Membrane Changes During Intraocular Surgery
- •Corneal Endothelial Changes From Intraocular Surgery
- •Conjunctival and Corneal Changes From Extraocular Surgery
- •14 Treatment of Ocular Surface Disorders
- •Surgical Procedures of the Ocular Surface
- •Limbal Transplantation
- •Autologous Conjunctival Transplantation
- •Pterygium Excision
- •Mucous Membrane Grafting
- •Conjunctival Flap
- •Conjunctival Biopsy
- •Conjunctivochalasis Excision
- •Therapeutic Interventions for Corneal Disease
- •Superficial Keratectomy and Corneal Biopsy
- •Management of Descemetocele, Corneal Perforation, and Corneal Edema
- •Corneal Tattoo
- •Tarsorrhaphy
- •15 Clinical Approach to Corneal Transplantation
- •Corneal Transplantation
- •Eye Banking and Donor Selection
- •Criteria Contraindicating Donor Cornea Use
- •Surgical Approach to Corneal Disease
- •Preoperative Evaluation and Preparation
- •Penetrating Keratoplasty
- •Surgical Technique for Penetrating Keratoplasty
- •Combined Procedures
- •Intraoperative Complications
- •Postoperative Care and Complications
- •Control of Postoperative Corneal Astigmatism and Refractive Error
- •Diagnosis and Management of Graft Rejection
- •Pediatric Corneal Transplantation
- •Corneal Autograft Procedures
- •Keratoprosthesis
- •Lamellar Keratoplasty
- •Anterior Lamellar Transplantation
- •Surgical Technique
- •Postoperative Care and Complications
- •Endothelial Keratoplasty
- •DSEK Surgical Technique and Complications
- •Descemet Membrane Endothelial Keratoplasty
- •Basic Texts
- •Related Academy Materials
- •Requesting Continuing Medical Education Credit
Figure 13-3 Severe, grade IV alkali burn with epithelial loss and stromal necrosis. (Courtesy of James J. Reidy, MD.)
Acid Burns
Acids denature and precipitate proteins in the tissues they contact. Acidic solutions tend to cause less severe tissue damage than do alkaline solutions because of the buffering capacity of tissues as well as the barrier to penetration formed by precipitated protein. The exception to this is hydrofluoric acid, which can cause significant anterior segment destruction. Acids do not directly cause loss of the proteoglycan ground substance in the cornea, although they too can incite severe inflammation and damage to the corneal matrix.
Management of Chemical Injuries
Many of the current recommendations for management are based on animal models of acute alkaline injury.
The most important step in the management of chemical injuries is immediate and copious irrigation of the ocular surface with water or balanced saline solution. If these liquids are not available, any other generally nontoxic and unpolluted solutions can also be used to avoid delaying treatment. Commercially available eyewash solutions such as Cederroth Eye Wash (Cederroth, Upplands Väsby, Sweden) may have some advantages over plain saline solutions. If possible, irrigation should be initiated at the site of the chemical injury and continued until an ophthalmologist evaluates the patient. The eyelid should be immobilized with a retractor or eyelid speculum, and topical anesthetic should be instilled. Irrigation may be accomplished using handheld intravenous tubing, an irrigating eyelid speculum, or a Morgan medi-FLOW Lens (MorTan, Missoula, MT), a special scleral contact lens that connects to intravenous tubing. Irrigation should continue until the pH of the conjunctival sac normalizes. The conjunctival pH can be checked easily with a urinary pH strip. If this is not available, it is better to “overtreat” for prolonged periods of irrigation than to “guess” that the pH has normalized.
Because they can continue to release the toxic chemical, particulate chemicals should be removed from the ocular surface with cotton-tipped applicators and forceps. Eversion of the upper eyelid should be performed to search for material in the upper fornix (Fig 13-4), and the fornices should be swept with an applicator to ensure that no particulate matter remains in the eye.
Figure 13-4 A, B, C, and D show steps in fashioning an eyelid retractor from a paper clip. E, Using the retractor for double eversion reveals a foreign body on upper eyelid. (Courtesy of John E. Sutphin, MD.)
The next phase of management should be directed at decreasing inflammation, monitoring intraocular pressure (IOP), limiting matrix degradation, and promoting reepithelialization of the cornea. An intense polymorphonuclear (PMN) leukocyte infiltration of the corneal stroma has been known to occur in acute alkali burns. PMNs may be a major source of proteolytic enzymes capable of dissolving corneal stromal collagen and ground substance. Corticosteroids are excellent inhibitors of PMN function, and intensive topical corticosteroid administration is recommended for the acute
phase (first 10–14 days) following chemical injuries. The dosage should be markedly reduced after 10–14 days, because corticosteroids can inhibit wound healing and possibly exacerbate sterile stromal melting. Corticosteroids also increase the risk of secondary infection by means of inhibition of normal ocular surface immune mechanisms; thus, their untoward side effects in the chronic phase may exceed their beneficial effects.
A deficiency of calcium in the plasma membrane of PMNs inhibits their ability to degranulate, and both tetracycline and citric acid are potent chelators of extracellular calcium. Therefore, oral tetracyclines and topical 10% sodium citrate have theoretical benefits for inhibiting PMN-induced collagenolysis. In addition, topical 1% medroxyprogesterone may be effective in suppressing collagen breakdown and is used in some centers.
Topical cycloplegics are recommended for patients with significant anterior chamber reaction. In the early stage of the injury, there may be a rise in IOP, which can be controlled by use of oral carbonic anhydrase inhibitors in order to avoid toxicity from topical glaucoma medications. However, if the corneal epithelium is healing normally, topical therapies may be used as well. BCSC Section 10, Glaucoma, discusses medications for IOP control in depth.
Measures to promote wound healing and inhibit collagenolytic activity may help prevent stromal ulceration. Severe alkali burns in rabbit eyes have been found to reduce aqueous humor ascorbate levels to one-third of normal levels. Reduced aqueous humor ascorbate has been correlated with corneal stromal ulceration and perforation. Systemic administration of ascorbic acid to rabbits with acute corneal alkaline injuries has restored the aqueous humor ascorbate level to normal and significantly reduced the incidence of ulceration. High-dose ascorbic acid is believed to promote collagen synthesis in the alkali-burned eye because ascorbic acid is required as a cofactor for this synthesis. There is currently no widely accepted standard for administration of ascorbic acid to corneas after chemical injury, but one recommendation is for patients to receive 1–2 g of vitamin C per day. However, because this therapy is potentially toxic to the kidneys, patients with compromised renal function are not good candidates for this approach.
There are certain key practices that facilitate epithelial healing in acute and chronic chemical injury. Patients should be treated initially with intensive nonpreserved lubricants. Necrotic corneal epithelium should be debrided to minimize the release of inflammatory mediators produced by damaged epithelial cells and to promote reepithelialization. A bandage contact lens or temporary tarsorrhaphy may be beneficial for protecting ocular surface epithelium once it has begun to move onto the peripheral cornea. Sometimes, the bandage contact lens is not retained easily because of the swelling and inflammatory response. A tarsorrhaphy has the advantage of not increasing the risk of corneal infection, which is a concern with contact lens use in eyes with poor epithelium. Avascular sclera will usually not epithelialize until revascularization occurs. If scleral melting occurs, then a rotational tarsoconjunctival graft from the adjacent eyelid can be performed to promote revascularization.
Autologous conjunctival or limbal transplants from a patient’s uninvolved fellow eye may restore the integrity of the damaged corneal epithelium. Amniotic membrane transplantation may be helpful in suppressing inflammation and promoting reepithelialization and prevention of symblepharon formation, and it should be considered in the early postinjury phase. Limbal stem cell transplantation may be performed as soon as 2 weeks after chemical injury if no signs of corneal epithelialization have appeared. However, in general, the prognosis of limbal grafts is better when the eye is not very inflamed; thus, waiting until the acute inflammation has subsided is helpful. Similarly, the prognosis for corneal transplantation is improved if the ocular surface inflammation has resolved either through the passage of time (months to years) or after limbal stem cell grafting (ocular surface reconstruction), if necessary. Even when there is no active ocular surface inflammation, stromal
